References
Wright KD, Panetta JC, Onar-Thomas A et al (2015) Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections. Cancer Chemother Pharmacol 75:27–35
Cohen I (2004) Defining the appropriate dosage of folinic acid after high-dose methotrexate for childhood acute lymphocytic leukemia that will prevent neurotoxicity without rescuing malignant cells in the central nervous system. J Pediatr Hematol Oncol 26:156–163
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wright, K.D., Stewart, C.F. Response to: comment on “Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections”. Cancer Chemother Pharmacol 75, 877–878 (2015). https://doi.org/10.1007/s00280-015-2699-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00280-015-2699-6